MADD027

Regulatory Transparency vs Transaction Confidentiality

Business ContextRegulators may require extensive information about ownership, markets, financing, customers, technology, and transaction rationale. Providing sufficient transparency supports regulatory review, but broad disclosure can expose commercially sensitive information.

Mergers and Acquisitions TRIZ ResolutionClassify information according to regulatory necessity and confidentiality sensitivity. Use controlled submissions, confidentiality procedures, restricted access, and permitted redactions while providing regulators with the evidence required for review.

Applicable TRIZ Principles

Principle 1 – Segmentation classifies information according to disclosure requirements.

Principle 2 – Taking Out removes unnecessary sensitive information where permitted.

Principle 24 – Intermediary uses controlled channels for sensitive regulatory information.

Expected Outcome

Adequate regulatory transparency

Stronger confidentiality

Reduced information exposure

More efficient regulatory review

Decision IndicatorsEarly indicators that this contradiction is limiting M&A performance include:

Regulatory teams cannot obtain information because of confidentiality concerns.

Sensitive information is submitted without appropriate controls.

Disclosure decisions repeatedly delay filings.

Commercial teams are uncertain about information-access boundaries.

Confidentiality treatment is not planned before submissions begin.

Monitoring these indicators helps provide regulatory transparency while protecting sensitive transaction information.